Literature DB >> 3766524

Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation.

O Kucuk, H C Kwaan, J Frederickson, L Wade, D Green.   

Abstract

The influence of cardiopulmonary bypass on fibrinolytic activity was assessed by a sensitive clot lysis assay in eight patients undergoing coronary artery bypass operations. Fibrinolytic activity increased immediately after cardiopulmonary bypass was begun and remained elevated throughout the period of extracorporeal circulation. At the conclusion of the operative procedure, fibrinolytic activity returned to the normal range in all patients, and no subject had postoperative bleeding.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3766524     DOI: 10.1002/ajh.2830230306

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.

Authors:  Francesco Burzotta; Licia Iacoviello; Augusto Di Castelnuovo; Roberto Zamparelli; Andria D'Orazio; Concetta Amore; Rocco Schiavello; Maria Benedetta Donati; Attilio Maseri; GianFederico Possati; Felicita Andreotti
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

Review 2.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

3.  Effect of Gabexate mesilate on postoperative blood loss in cardiovascular surgery using cardiopulmonary bypass.

Authors:  A Kohyama; R Goh; K Mori; S Yasumoto; H Kimura; H Kitahata
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

Review 4.  Antifibrinolytic therapy in cardiac surgery.

Authors:  R H Chen; O H Frazier; D A Cooley
Journal:  Tex Heart Inst J       Date:  1995

5.  Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?

Authors:  B E Steinbrueckner; U Steigerwald; F Keller; K Neukam; O Elert; J Babin-Ebell
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

Review 6.  Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.

Authors:  R Davis; R Whittington
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 7.  Natural and synthetic antifibrinolytics in cardiac surgery.

Authors:  J F Hardy; J Desroches
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

8.  [The effect of intraoperative high-dose tranexamic acid on blood loss after operation for acute aortic dissection].

Authors:  Y Shimamura; M Nakajima; T Hirayama; H Misumi; T Shimokawa; H Uesugi; K Uemura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-07

9.  Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.

Authors:  Hosam Fawzy; Elsayed Elmistekawy; Daniel Bonneau; David Latter; Lee Errett
Journal:  J Cardiothorac Surg       Date:  2009-06-18       Impact factor: 1.637

10.  Does topical tranexamic acid reduce postcoronary artery bypass graft bleeding?

Authors:  Amir Mirmohammadsadeghi; Mohsen Mirmohammadsadeghi; Mahnaz Kheiri
Journal:  J Res Med Sci       Date:  2018-01-29       Impact factor: 1.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.